• English
  • 简体中文
Login Register
Current Location: Home > Marketing Drugs(EU) Feedback Help Print
Product No EMEA/H/C/001206
Brand Name Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals)
Nonproprietary Name pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)
API split influenza virus, inactivated, containing antigen: A/VietNam/1194/2004 (H5N1) like strain used (NIBRG-14)
ATC Code J07BB02
Indications Prophylaxis of influenza in an officially declared pandemic situation. Pandemic influenza vaccine should be used in accordance with official guidance.
Orphan Drug no
Generics no
Marketing Authorization Holder GlaxoSmithKline Biologicals S.A.
Status Authorised
Authorization Date 2009-10-10
Version 8
Condition Approval no
Exceptions yes
Biosimilar no
Details 查看 (公众评估报告、授权细节、产品规格/剂型、标签、历史评估信息)
Extended Information